• {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pselfProduct%}
      • {%cSlanguages%}
    • This Webiste is For Healthcare Professionals Practicing in Saudi Arabia Only

      Welcome to AbbVie Pro

      As AbbVie, we are deeply committed to making a remarkable impact on patient’s lives while empowering healthcare professionals with the latest insights and resources to elevate the standard of care.

      Immunology

       

      Oncology

       

      Neuroscience

       

      Eye Care

       

       

      Explore AbbVie News

      Experience the highlights of medicine at the AbbVie Hub.

      Our therapy areas

      Additional info

       

      •This material is funded and developed by AbbVie.

      •Material intended exclusively for healthcare professionals in Saudi Arabia for educational purposes.

      •This is a personal and non-transferable material, any total or partial reproduction, alteration, sharing, or improper use of this content without prior written authorization from the company is expressly prohibited.

      •All rights reserved. This material is protected by copyrights and other intellectual property protection laws.

       

      •In the event of any comments on the materials presented, please contact the Saudi Food & Drug Authority (SFDA) on the unified number 19999.

      •This Website is for healthcare professionals practicing in Saudi Arabia only.

       

      Scientific Office - Riyadh, Abraj Attawuneyyah, North Tower, 16th Floor

      P.O. Box 9710, Riyadh 11423

      Office: +966 11 229 4200
      Fax: +966 11 299 4288
      Website: www.abbvie.com

       

      For adverse events reporting:
      Email: PV.MEA@abbvie.com
      Hotline number: +966 55 828 2010

      JAKa-SA-00017-MC / Preparation Date: May 2023